# Multiple Ascending Dose Study of DS-1093 in Healthy Subjects

> **NCT02142400** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 31 (actual)

## Conditions studied

- Anaemia

## Interventions

- **DRUG:** DS-1093
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02142400
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02142400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02142400, "Multiple Ascending Dose Study of DS-1093 in Healthy Subjects". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT02142400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*